Eli Lilly and Company (LLY) Institutional Holders & Insider Trades

Eli Lilly and Company

LLY · NYSE

Symbol: LLY
Type: Stock
Sector: Health Care
Industry: Biotechnology: Pharmaceutical Preparations
Country: North America
Exchange: NYSE

Lilly is a medicine company turning science into healing to make life better for people around the world. We've been pioneering life-changing discoveries for 150 years, and today our medicines help tens of millions of people across the globe. Harnessing the power of biotechnology, chemistry and genetic medicine, our scientists are urgently advancing new discoveries to solve some of the world's most significant health challenges: redefining diabetes care; treating obesity and curtailing its most devastating long-term effects; advancing the fight against Alzheimer's disease; providing solutions to some of the most debilitating immune system disorders; and transforming the most difficult-to-treat cancers into manageable diseases. With each step toward a healthier world, we're motivated by one thing: making life better for millions more people.

Key Issues

Bullish view

Strong demand for Lilly’s GLP-1 drugs is driving rapid revenue growth, and the company cited continued strength in key products when raising its full-year revenue outlook.

Bearish view

The Motley Fool’s discussion of whether the stock is running out of steam highlights the risk that investor expectations and the GLP-1 growth narrative may already be too demanding.

Analyst Consensus

See all

Buy

23 analysts

$1,165

Current

—

Low

$1,300

Average

—

High

Average target implies +11.54% versus the current price.

Earnings History

BeatMissNo estimate

Peers

Johnson & JohnsonJNJ · NYSE

100 filers$875.86B loaded

Manager	Filing date	Shares	Value	Change
Lilly Endowment Inc	Jun 30, 2026	90.38M	$100.83B	-1.65%
Vanguard Group Inc	Dec 31, 2025	81.97M	$91.45B	+0.17%
Blackrock, Inc.	Mar 31, 2026	67.01M	$74.76B	-0.56%
Vanguard Capital Management Llc	Mar 31, 2026	53.36M	$59.53B	0.00%
Pnc Financial Services Group, Inc.	Mar 31, 2026	51.33M	$57.27B	-0.01%
State Street Corp	Mar 31, 2026	35.61M	$39.73B	+0.70%
Fmr Llc	Mar 31, 2026	33.19M	$37.03B	-4.30%
Capital Research Global Investors	Mar 31, 2026	24.63M	$27.48B	+0.27%
Vanguard Portfolio Management Llc	Mar 31, 2026	20.98M	$23.40B	0.00%
Capital World Investors	Mar 31, 2026	20.45M	$22.82B	+26.34%
Geode Capital Management, Llc	Mar 31, 2026	20.30M	$22.65B	+2.02%
Morgan Stanley	Mar 31, 2026	19.71M	$21.99B	+17.98%
Jpmorgan Chase & Co	Mar 31, 2026	14.18M	$15.82B	+8.38%
Price T Rowe Associates Inc /Md/	Mar 31, 2026	13.99M	$15.61B	-25.72%
Wellington Management Group Llp	Mar 31, 2026	13.43M	$14.98B	+0.15%
Bank Of America Corp /De/	Mar 31, 2026	13.06M	$14.57B	+8.32%
Norges Bank	Dec 31, 2025	12.07M	$13.47B	+6.63%
Avoro Capital Advisors Llc	Mar 31, 2026	11.43M	$12.75B	-21.47%
State Farm Mutual Automobile Insurance Co	Mar 31, 2026	10.76M	$12.00B	-13.79%
Index Venture Life Associates Vi Ltd	Mar 31, 2026	9.96M	$11.11B	0.00%
Adage Capital Partners Gp, L.L.C.	Mar 31, 2026	9.88M	$11.02B	-18.43%
Primecap Management Co/Ca/	Mar 31, 2026	9.22M	$10.29B	-0.46%
Northern Trust Corp	Mar 31, 2026	8.83M	$9.85B	-0.09%
Pentwater Capital Management Lp	Mar 31, 2026	8.17M	$9.12B	0.00%
Janus Henderson Group Ltd.	Mar 31, 2026	7.84M	$8.75B	-8.14%
Goldman Sachs Group Inc	Mar 31, 2026	7.49M	$8.35B	+11.24%
Ubs Am, A Distinct Business Unit Of Ubs Asset Management Ame	Mar 31, 2026	7.07M	$7.89B	+8.81%
Capital International Investors	Mar 31, 2026	6.12M	$6.82B	-38.02%
Ecor1 Capital, Llc	Mar 31, 2026	6.00M	$6.69B	+92.62%
Charles Schwab Investment Management Inc	Mar 31, 2026	5.90M	$6.58B	+2.42%
Legal & General Group Plc	Mar 31, 2026	5.49M	$6.12B	+1.68%
Jennison Associates Llc	Jun 30, 2026	5.46M	$6.09B	+7.91%
Nuveen, Llc	Mar 31, 2026	5.34M	$5.96B	-1.78%
Perceptive Advisors Llc	Mar 31, 2026	5.26M	$5.87B	+80.25%
Franklin Resources Inc	Mar 31, 2026	5.16M	$5.75B	-26.20%
Fisher Asset Management, Llc	Jun 30, 2026	5.06M	$5.65B	+4.64%
Amundi	Mar 31, 2026	5.06M	$5.64B	+9.88%
Bank Of New York Mellon Corp	Mar 31, 2026	4.87M	$5.43B	-4.40%
Farallon Capital Management, L.L.C.	Mar 31, 2026	4.81M	$5.37B	-10.56%
Vanguard Fiduciary Trust Co	Mar 31, 2026	4.62M	$5.15B	0.00%
Alliancebernstein L.P.	Mar 31, 2026	4.43M	$4.94B	-4.18%
Wells Fargo & Company/Mn	Mar 31, 2026	4.41M	$4.92B	+1.75%
Ubs Group Ag	Mar 31, 2026	4.40M	$4.91B	+7.37%
Tcg Crossover Management, Llc	Mar 31, 2026	4.29M	$4.78B	0.00%
Royal Bank Of Canada	Mar 31, 2026	4.26M	$4.76B	-2.55%
Dimensional Fund Advisors Lp	Mar 31, 2026	3.90M	$4.35B	+3.30%
Deutsche Bank Ag\	Mar 31, 2026	3.74M	$4.17B	-5.70%
Paradigm Biocapital Advisors Lp	Mar 31, 2026	3.57M	$3.99B	0.00%
Invesco Ltd.	Mar 31, 2026	3.46M	$3.86B	+14.97%
Deep Track Capital, Lp	Mar 31, 2026	3.16M	$3.52B	+57.90%